![](/images/graphics-bg.png)
Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain
Joint Authors
Aporta Rodriguez, Rafael
García Montero, Mariola
Lorente Aporta, Jose Pablo
Gallego Luque, Carolina
Chacón Mayor, Alfonso
Aragón Ruiz, Jose
Torres Degayón, Virginia
García Jimenez, Claudia
Sanchez Sanchez, Guadalupe
Source
Obstetrics and Gynecology International
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-10-20
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Iron deficiency and iron deficiency anemia during pregnancy call for safe treatment options that raise maternal hemoglobin levels and counterbalance iron demand and blood volume expansion while minimizing risks for the growing fetus.
This retrospective study describes experience with intravenous ferric carboxymaltose given to pregnant women in a tertiary hospital in Spain.
In a 5-year period, 95 pregnant women who had pretreatment hemoglobin <10 g/dL and at least one time of ferric carboxymaltose administration during pregnancy were included.
Main outcome measures were week of pregnancy at iron administration, Hb levels before and after treatment, neonatal 5-minute Apgar scores, and birth weight.
The majority received one dose of ferric carboxymaltose (1000 mg iron) during advanced pregnancy (median 31 weeks; interquartile range [IQR]: 27; 37 weeks) with minor to no adverse outcomes.
Overall, median Hb increased from 8.5 g/dL (8.1; 8.9 g/dL) before treatment to 11.0 g/dL (9.9; 11.7 g/dL) after treatment.
Normal Apgar scores were observed in all 97 infants (median birth weights 3560 g, 3270, and 3798 g).
Four women received ferric carboxymaltose in the first trimester and twenty-eight during the second trimester without adverse outcomes for mother or child.
These cases add to the evidence that ferric carboxymaltose administration during pregnancy is effective and safe.
American Psychological Association (APA)
Aporta Rodriguez, Rafael& García Montero, Mariola& Lorente Aporta, Jose Pablo& Gallego Luque, Carolina& Chacón Mayor, Alfonso& Aragón Ruiz, Jose…[et al.]. 2016. Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain. Obstetrics and Gynecology International،Vol. 2016, no. 2016, pp.1-5.
https://search.emarefa.net/detail/BIM-1113500
Modern Language Association (MLA)
Aporta Rodriguez, Rafael…[et al.]. Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain. Obstetrics and Gynecology International No. 2016 (2016), pp.1-5.
https://search.emarefa.net/detail/BIM-1113500
American Medical Association (AMA)
Aporta Rodriguez, Rafael& García Montero, Mariola& Lorente Aporta, Jose Pablo& Gallego Luque, Carolina& Chacón Mayor, Alfonso& Aragón Ruiz, Jose…[et al.]. Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain. Obstetrics and Gynecology International. 2016. Vol. 2016, no. 2016, pp.1-5.
https://search.emarefa.net/detail/BIM-1113500
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1113500